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Summary We previously reported that psychological stress is linked to and
possibly accelerates cellular aging, as reﬂected by lower PBMC telomerase and
shortened telomeres. Psychological stress is a major risk factor for cardiovascular
disease (CVD), with multiple behavioral and physiological mediators. Telomere
shortness has been associated with CVD, but the relationship between low
telomerase activity, a potential precursor to telomere shortening, and CVD risk
factors has not been examined in humans. Here we examine whether telomere
length and telomerase in leukocytes are associated with physiological signs of
stress arousal and CVD risk factors in 62 healthy women. Low telomerase activity
in leukocytes was associated with exaggerated autonomic reactivity to acute
mental stress and elevated nocturnal epinephrine. Further, low telomerase
activity was associated with the major risk factors for CVD —smoking, poor lipid
proﬁle, high systolic blood pressure, high fasting glucose, greater abdominal
adiposity—as well as to a composite Metabolic Syndrome variable. Telomere
length was related only to elevated stress hormones (catecholamines and
cortisol). Thus, we propose that low leukocyte telomerase constitutes an early
marker of CVD risk, possibly preceding shortened telomeres, that results in part
from chronic stress arousal. Possible cellular mechanisms by which low
telomerase may link stress and traditional risk factors to CVD are discussed.
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1. Introduction
We recently reported that chronic psychological
stress was associated with both shorter telomere
length and lower telomerase activity in leukocytes
(Epel et al., 2004). Telomeres are DNA-protein
complexes that cap chromosomal ends and promote
chromosomal stability. Telomere length is the
downstream output of the actions of both lengthen-
ing and shortening activities in the cell (Blackburn,
2000).Mostnotably,thecellularenzymetelomerase
adds telomeric repeat sequences to the chromo-
somalDNAends,preservingnotonlytelomerelength
but also healthy cell function, prolonged stem cell
proliferation, and long-term immune function,
independently of telomere length (Kim et al.,
2003; Ly et al., 2005; Marrone et al., 2005).
Stress arousal is likely to be one pathway through
which chronic stress may impact cellular aging
(Sapolsky, 2004). Chronic life stress can lead to
overexposure to stress responsive adrenal hor-
mones, primarily cortisol and catecholamines, or
tohyporesponsiveness,alsoreﬂectingdysregulation
(McEwen, 1998). In addition to adrenal hormones,
autonomic nervous system reactivity to stress,
particularly heart rate variability, can serve as a
physiological index of stress vulnerability, and is
related to anxiety (Porges, 1995; Friedman and
Thayer, 1998). We thus examined whether telomer-
ase levels and telomere length in peripheral blood
mononucleocytes (PBMCs) are associated with two
indices of stress arousal—nocturnal excretion of
stress hormones (catecholamines and cortisol) and
autonomic nervous system stress reactivity to a
standardized stressor (vagal tone or heart rate
variability).
Psychological stress has recently emerged as one
of the major risk factors for CVD. The largest
epidemiological study of risk factors for CVD to
date, with almost 30,000 participants, across 52
countries, identiﬁed the top six modiﬁable risk
factors: cigarette smoking, poor lipid proﬁle, high
bloodpressure,diabetes,abdominalobesity,andan
indexofpsychosocialstress(Yusefetal.,2004).The
cellular mechanisms by which many of these
physiological and behavioral risk factors, particu-
l a r l ys t r e s s ,c a nl e a dt od i s e a s ea r en o tw e l l
understood.
However, there is now converging evidence from
basic and clinical studies that telomere mainten-
ance plays an important role in organismal
longevity. Shorter telomeres in human leukocytes
have been linked to age-related conditions and
diseases including hypertension, greater pulse
pressure, hypercholesterolemia (reviewed in Ser-
rano and Andres, 2004), and increases in insulin
resistance (Gardner et al., 2005). Moreover, in the
only prospective study of telomere length and
longevity, telomere length predicted earlier mor-
tality, particularly from infections and CVD (Caw-
thon et al., 2003). It is unknown exactly how
telomere maintenance might inﬂuence CVD pro-
cesses. Telomerase increases telomere length.
Although telomerase has not been examined in
relation to CVD risk in humans, telomerase insufﬁ-
ciency leads to bone marrow failure (Marrone et al.,
2005), while in animal studies and in vitro, telomer-
ase insufﬁciency has been linked to cardiovascular
pathobiology (Yang et al., 1999; Oh, 2003). These
ﬁndings raise the possibility that telomerase may
play an important role in early development of CVD
in humans.
Given the inter-relationships between stress,
telomere length and CVD risk factors, in the present
study we also examined the relationship between
cellular aging and CVD risk factors. We tested
whether telomere length and telomerase were
related to early development of the top CVD risk
factors, in a sample of healthy young women (i.e.
those without frank disease). Further, many CVD
risk factors tend to be correlated, representing
underlying insulin resistance, labeled as the Meta-
bolic or Insulin Resistance Syndrome (Reaven,
1988). The Metabolic Syndrome tends to accrue
with aging and is a well-established precursor to
chronic diseases, most notably CVD (Lakka et al.,
2002). Therefore, we examined whether cell aging
was linked to this underlying syndrome, in addition
to individual risk factors. We speciﬁcally tested the
hypothesis that women with greater levels of
cellular aging (i.e. shorter PBMC telomere length
and lower telomerase activity) would have greater
stress arousal and CVD risk factors, including level
of Metabolic Syndrome.
2. Materials and methods
2.1. Study overview
Sixty-two healthy women (all mothers), aged 20–50,
were assessed on mood, life stress, acute mental
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laboratory stressor, and health parameters, includ-
ing a blooddraw. Within 1 week after the laboratory
assessment, participants completed questionnaires
assessing stress (Perceived Stress Scale) (Cohen and
Williamson, 1988), tendency to experience nega-
tive mood (Positive and Negative Assessment Scale)
(Watson et al., 1988), years of education com-
pleted, and health behaviors, and completed an
overnight collection of urine from home, to be
assayed for stress hormones.
2.2. Participants and recruitment
Participants were initially recruited through their
child’s health care professional in clinics in Bay
Area hospitals, or by public postings. To capture a
range of stress levels, the sample included both
mothers of chronically ill children and mothers of
healthy children. All women had at least one
biological child, and of these participants, 40
were mothers of children with a neurological or
gastrointestinal disorder, or a pervasive develop-
ment disorder (i.e. autism), and 22 had healthy
children (for more detail, see (Epel et al.,
2004).This is the same sample of study participants
for which relationships between chronic psycho-
logical stress and telomere length, telomerase and
oxidative stress were previously reported(Epel
et al., 2004), (with the addition of four additional
participants who had measures of telomerase and
other parameters but not telomere length). Telo-
merase activity and telomere length in PBMCs were
measured as described previously (Epel et al.,
2004). The 62 participants were free of any acute
or chronic health conditions by self report, with the
exception of controlled hypertension (nZ2) and
controlled hypothyroidism (nZ1). Participants did
not take any other regular medications, except oral
contraceptives (nZ19, 30.6%), and antidepressants
(nZ4). All women were currently menstruating.
Nine percent currently smoked (nZ5), but
refrained from smoking the morning of the blood
draw. Participants did not consume more than
seven alcoholic beverages per week, or exercise
more than 1 h a day. They refrained from alcohol
the day before the study and during the study day.
2.3. Laboratory session
The laboratory sessions took place at the Oakland
Children’s Hospital Pediatric Clinical Research
Center. Efforts to minimize hormonal variability
from menstrual cycle stages included timing
sessions as follows: Sessions occurred during the
ﬁrst 7 days of the follicular phase of the menstrual
cycle, when estrogen and progesterone are lowest.
For those taking oral contraceptives, in the
majority of cases, women participated during the
‘placebo week’ when hormone levels are also
lowest.
Participants fasted for 10 h, starting from after
dinner the previous night, and had a fasting blood
draw around 0800 h on the test day. Additional
assessments included smoking status, resting hemo-
dynamics, adiposity, blood insulin, glucose and lipid
proﬁle. PBMCs were isolated immediately from the
blood, and frozen at K80 8C. Telomerase activity
levels and telomere length were measured from
frozen cells (O80% viability; telomerase activity
levels measured are shown corrected to arbitrary
units per viable cell). All participants were then
exposed to a standardized laboratory stressor,
while autonomic nervous system reactivity (cardiac
vagal control or high frequency heart rate varia-
bility) was measured repeatedly. Detailed pro-
cedures are described below.
2.4. Standardized stressor
Participants were exposed to an adapted version of
the standardized Trier Social Stress Test (Kirsch-
baum et al., 1993). They ﬁrst rested for 30 min
before sitting baseline measurements of autonomic
arousal were taken for 5 min. Participants were
given task instructions, and then exposed to 15 min
of stressful tasks, including a 5-min speech prep-
aration period, deliverance of a 5-min videotaped
speech with a live audience of two people, and a
5-min performance of serial subtraction of a prime
number from a high number. They performed these
tasks while seated to limit movement that could
affect the psychophysiology recordings.
2.4.1. Cardiovascular and autonomic reactivity
Cardiovascular beat-to-beat data were assessed at
baseline, during mental stress, including the
anticipation/preparation period, speech stressor,
and arithmetic stressor. An automatic arm cuff
inﬂation blood pressure monitor (model SD-700S,
IBS, Waltham, MA) was triggered 4 min after onset
of each task, and systolic and diastolic values were
recorded on a log sheet. A customized computer
program written in MATLAB (Wilhelm et al., 1999)
was used for computation of heart rate and high
frequency HRV (also termed respiratory sinus
arrhythmia, RSA, an index of cardiac vagal control).
The beat-to-beat values of inter-beat intervals (IBI)
were edited for outliers due to artifacts or ectopic
myocardial activity, linearly interpolated, and
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resolution of 4 Hz. IBI series were linearly
detrended, and the power spectral densities
derived for each experimental period using the
Welch algorithm, which ensemble averages succes-
sive periodograms (a total of 9 240-point segments,
overlapping by 50%, were Hanning windowed, zero
padded to length 256, and subjected to Fast Fourier
transform; estimates of power were adjusted to
account for attenuation produced by the Hanning
window). High-frequency HRV was computed by
summation of power spectral density values in the
0.15–0.50 Hz frequency range, and resulting values
were normalized using the natural logarithm.
2.5. Urine sampling
A subsample of 41 participants collected a 12 h
nocturnal urine sample which was assayed for
stress hormones (cortisol, epinephrine, and nor-
epinephrine) and creatinine on one night in the
week following the session, typically from 2000
to 0800 h (to assess resting arousal, minimizing
contributions from daytime activity levels).
Selection of the subsample was based simply on
the timing of implementation of the urine
collection (the participants run in the ﬁrst few
months did not collect urine). The urine was kept
in a cooler with ample ice blocks for the duration
of the collection, and picked up promptly the
next morning. Aliquots were taken and frozen at
K808C until batch analysis (to minimize inter-
assay variation). The range of collection times
was from 11.75 to 12.75 h, with 90% of the
sample collecting for a full 12 h. Urinary
hormones were analyzed as ng/mg creatinine,
to adjust for differences in durations of collec-
tions and in body mass. Participants who had
collection volumes less than 300 ml (nZ4) were
determined to have incomplete collections and
their urinary hormone values were excluded from
analyses, as done in other studies with 12 h urine
collections (e.g. Greendale et al., 1999). Values
were normally distributed, and results were
similar when using a natural log transformation
(raw values are shown). Assays were done in the
laboratory of Dr Robert Chatterton, Northwestern
University. Urinary epinephrine and norepi-
nephrine were assayed with kits provided by
American Laboratory Products Company (Alpco),
Windham, NH. The sensitivity is 0.33 and 1.33 ng/
ml, respectively, for epinephrine and norepi-
nephrine. For epinephrine the intra- and inter-
assay coefﬁcients of variation (CV’s) were 7.2 and
15.4%, respectively. For norepinephrine, the
intra- and interassay CVs were 10.2 and 15.0%,
respectively. Cortisol was measured by a radio-
immunoassay. The sensitivity of the method is
10 nml. Intra- and interassay CVs were 9.3 and
5.4%, respectively. Creatinine was measured
spectrophotometrically by the Jaffe reaction at
490 nm after extraction of the samples with ethyl
ether to remove interfering substances.
2.6. Cardiovascular disease risk
and metabolic syndrome composite
Weight was measured using a balance beam scale,
and height with a stadiometer. BMI was calculated
as weight (kg)/height (m)2. Saggital diameter was
measured with a meter stick with a leveler on the
top, as the widest horizontal diameter from the
lower lumbar to the belly, a measure which is highly
correlated with visceral fat from CT scans (Kvist
et al., 1988).
Lipid levels were analyzed in triplicate in the
Core Laboratory of the GCRC at the Medical College
of Wisconsin (RR00058). Fasting plasma triglyceride
and cholesterol levels were determined spectro-
photometrically using kits from Stanbio Laboratory,
Inc. (San Antonio, TX), and Roche Diagnostics
(Indianapolis, IN), respectively. HDL-cholesterol
was determined after phosphotungstic acid/MgCl2
precipitation (Sigma Diagnostics, St Louis, MO). The
respective intraassay and interassay coefﬁcients of
variation for the lipid analyses were 4.7 and 5.3% for
triglyceride, 5.5 and 6.7% for cholesterol, and 5.7
and 6.1% for HDL-cholesterol. LDL cholesterol level
was derived with the formula Total Cholesterol—
(0.20
*TriglycerideCHDL). Insulin and glucose were
measured in the Cornell GCRC, using standard
methods with commercial kits.
The ‘National Cholesterol Education Program
(NCEP) Adult Treatment Panel III (ATPIII)’ deﬁ-
nition for Metabolic Syndrome includes scoring in
the elevated range on at least three of the
following symptoms: abdominal obesity, triglycer-
ides, low HDL, high blood pressure, and high
fasting glucose (NCEP, 1999). To examine the
subclinical level of cumulative risk factors in a
healthy sample who would not meet threshold for
full blown Metabolic Syndrome, we examined the
level of Metabolic Syndrome by creating a
continuous measure of how high one is on each
of these ﬁve factors. Each factor, waist circum-
ference, HDL cholesterol, triglycerides, systolic
blood pressure, and glucose levels, was standar-
dized, and a mean was taken. Higher mean z
scores represent a greater extent of Metabolic
Syndrome.
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Our primary goal was to test whether women with
differing levels of cellular aging differed in stress
arousal and CVD risk factors. Participants were
categorized into high and low telomerase activity
groups, and high and low telomere length groups,
based on mean splits. T-tests, with 1-tailed
signiﬁcance tests for a priori hypotheses, were
performed to test for any differences between
these cell aging groups. To follow up these
analyses, we tested whether ﬁndings were inde-
pendent of the two major confounding factors, age
and BMI, by performing analyses of covariance
(ANCOVAs) adjusting for these factors with these
covariates. There were no signiﬁcant differences in
telomerase activity or telomere length overall
between the caregiving vs. control groups, and
thus these women were examined as one group. All
variables were examined for normal distributions,
and transformed when appropriate (i.e. telomerase
was slightly positively skewed, and thus log
transformed).
4. Results
4.1. Stress arousal
We found that lower telomerase levels were related
to neuroendocrine and psychosocial data indicative
of greater life stress. ANCOVAs showed that the
women with low telomerase had signiﬁcantly higher
excretion of nocturnal epinephrine (p!.01), and
marginally higher norepinephrine (p!.08) but
similar levels of cortisol (See Fig. 1 for standardized
values, adjusted for BMI and age). The low
telomerase group was not signiﬁcantly different in
negative affect, although when examined as a
continuous variable, telomerase (log transformed)
was correlated with trait negative mood (using the
PANAS) (rZK.31, p!.02), and as reported else-
where, with perceived stress and chronicity of
stress (Epel et al., 2004). Low telomerase was also
associated with fewer years of education (Table 1),
which is itself a risk factor for CVD, in part through
conferring greater exposure to chronic stress
(Wamala et al., 1999).
To examine autonomic reactivity to stress (heart
rate, blood pressure, and HRV), repeated measure
ANCOVAs were performed, controlling for baseline
values of each dependent variable, BMI, and age.
Groups were similar in blood pressure and heart
rate reactivity. However, the low telomerase group
responded to stress with greater decreases in HRV,
compared to the high telomerase group (Fig. 2).
Average HRV during stress controlling for baseline
HRV, age, and BMI was lower in the low telomerase
group: F(1,40)Z3.85, p!.028).
Telomere length, unlike telomerase, was not
related to negative mood, education, or HRV.
Shorter telomere length was, however, signiﬁcantly
related to higher levels of all three stress hormones
measured (cortisol, epinephrine, and norepi-
nephrine), after controlling for BMI and age (p’s!
.05, see Fig. 1 for standardized levels).
4.2. Cardiovascular disease risk
As shownin Table 1,t-testsreveal that although age
was similar between the high and low telomerase
groups, the low telomerase group had signiﬁcantly
greater BMI and abdominal adiposity (saggital
diameter), and higher resting heart rate, systolic
blood pressure, fasting glucose, LDL and total
cholesterol, total/HDL cholesterol ratio, and a
greater tendency toward lower resting HRV. They
were also more likely to be smokers; although there
were only ﬁve current smokers, all were in the low
Figure 1 Nocturnal urinary stress hormones (ng/ml
creatinine, standardized values), adjusted for BMI and
age. (A) Low and high telomerase activity groups. (B)
Short and long telomere length groups. *Zp!.05, levels
are higher compared to levels of the same hormone in the
other (high/long) group.
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by smoking group: X
2(1)Z4.77, p!.015), falling
within the bottom 15% of all telomerase values
(Fig. 3).
Because obesity both may be linked to low
telomerase (via unknown pathways) and also could
generate the other risk factors, BMI (and age)
were controlled for using ANCOVAs. As shown in
Table 1, differences between the low and high
telomerase groups in systolic blood pressure and
Metabolic Syndrome composite became non-sig-
niﬁcant and thus were partially mediated via BMI
(age was not different between groups, only BMI).
In contrast, heart rate, lipids, and fasting glucose
differences remained signiﬁcant and hence were
independent of BMI. We performed the same
analyses with telomere length groups but did not
observe associations between telomere length and
CVD risk.
5. Discussion
Chronic psychological stress has been associated
both with signs of accelerated leukocyte aging in
our current sample (Epel et al., 2004) and with
CVD in large samples (e.g. Yusef et al., 2004),
but the intermediate mediators of these relation-
ships have not been characterized. The present
study represents a ﬁrst test of whether leukocyte
aging might potentially underlie the relationship
between stress and CVD risk factors. We found
that telomere shortness and low telomerase are
both associated with stress arousal (nocturnal
stress hormones), and low telomerase is associ-
ated with several risk factors for CVD, as
discussed below. It is likely that stress hormones
play an important role in the pathway to cellular
aging. These ﬁndings support a tentative role for
telomerase in the pathway between stress and
disease. Further research is needed to determine
the mechanisms of how the telomerase/telomere
maintenance system might play a causal role in
CVD, whether stress is an early precursor, and
how genetic predispositions might promote vul-
nerability to these related factors (stress arousal,
cellular aging).
5.1. Stress arousal
This is the ﬁrst clinical study to our knowledge to
document relationships between stress hormones
Table 1 Raw means and standard errors of age, education, and CVD risk factors in high and low telomerase groups.
High telomerase
M (SE) NZ29
Low telomerase
M (SE) NZ33
t-test values, sig-
niﬁcance (1-
tailed)
Signiﬁcance
after adjust-
ing for BMI,
age (ANCOVA)
Age (years) 39.4 (1.0) 37.2 (1.2) K1.41, p!.14 N/A
Education (years) 15.50 (0.35) 14.5 (0.33) K2.02, p!.025 N/A
Adiposity
Body mass index (BMI; kg/m
2) 23.99 (0.68) 27.44 (1.12) 2.55, p!.007 N/A
Sagittal diameter (cm) 19.22 (0.88) 22.09 (1.01) 2.12, p!.019 N/A
Resting cardiovascular activity
a
Systolic blood pressure (mm Hg) 105.04 (1.79) 109.83 (1.60) 2.00, p!.025 p!.150
Diastolic blood pressure (mm Hg) 64.96 (1.85) 68.10 (1.53) 1.36, p!.09 p!.330
Heart rate (bpm) 76.56 (1.90) 82.58 (1.85) 2.27, p!.015 p!.041
High frequency heart rate varia-
bility (ms
2)
6.40 (0.11) 6.15 (0.09) K1.67, p!.051 p!.054
Cholesterol levels
HDL (mg/dl) 50.11 (1.96) 45.93 (2.55) K1.30, p!.095 p!.300
LDL (mg/dl) 119.11 (6.39) 142.97 (9.46) 2.37, p!.011 p!.012
Total (mg/dl) 184.14 (7.0) 203.31 (8.56) 1.72, p!.045 p!.016
Total/HDL ratio 3.77 (0.17) 4.83 (0.34) 2.73, p!.005 p!.017
Fasting insulin (uIU/mL) 12.33 (1.56) 11.81 (1.29) K0.26, p!.395 p!.463
Fasting glucose (mg/dL) 84.33 (0.94) 88.69 (1.40) 2.55, p!.007 p!.008
Metabolic syndrome
(mean z-score)
K.21 (.09) .13 (.09) 2.65, p!.006 p!.09
N/AZnot applicable.
a Cardiovascular results are after excluding the two subjects on antihypertensive medications.
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in vitro). Telomerase status and telomere length
are well established indices of cellular health and
longevity (Blackburn, 2000). Here we show that low
telomerase and short telomeres are both related to
elevations in nocturnal excretion of epinephrine
(and short telomeres to elevations in norepi-
nephrine and cortisol). These results are consistent
withour earlier ﬁndings that greater perception and
duration of psychological stress are related to
shorter telomere length and decreased telomerase
activity (Epel et al., 2004).
While both low telomerase and short bulk
telomere length were related to higher stress
hormones, mainly epinephrine, the remaining
tests showed signiﬁcant associations for telomer-
ase, but not for telomere length. There is a
consistent pattern linking telomerase activity to
additional indices of stress and stress arousal
(negative mood, lower education, autonomic arou-
sal), as well as CVD risk factors, and a lack of similar
associations for telomere length. In terms of
autonomic arousal, women with lower telomerase
activity levels tended to have higher resting heart
rate and somewhat lower resting cardiac vagal
control and greater vagal suppression (decreases in
high frequency HRV) in response to a standardized
laboratory stressor, all ﬁndings independent of age
and BMI. Chronically suppressed vagal control may
indicate impaired allostasis and restorative pro-
cesses, and increased risk for CVD, whereas vagal
suppression in response to acute stressors is a
physiological indicator of psychological stress
vulnerability, at least in infants (Porges, 1995;
Carney et al., 2001). Since parasympathetic
nervous system activity controls restorative pro-
cesses, it may be particularly important in promot-
ing longevity.
The direction of causality for the present ﬁndings
is unknown. Stress and associated stress arousal
may contribute to decreased telomerase activity,
since the opposite direction of causality seems less
probable. In vitro, catecholamines can reduce
Figure 2 High frequency HRV by telomerase groups.
Autonomic nervous system function at baseline and
during stressful tasks for low and high telomerase groups.
As shown above, across all timepoints, a quadratic model
best ﬁts the data, F(1,41)Z7.81, p!.004, showing lower
baseline but also a decrease in HRV during the stressor in
the low telomerase group only. Two subjects with
controlled hypertension were excluded (all values
adjusted for age and BMI). Base, baseline; Prep,
preparation/anticipation of speech; Speech, speech
task; Math, math task; Recovery, rest period.
Figure 3 Telomerase levels among smokers and non-
smokers. The ﬁve smokers had signiﬁcantly lower average
telomerase than the non-smokers, t-testZ3.26, p!.002.
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2001) but, more relevant to this study, peripheral
infusions of catecholamines increase oxidative
stress in rats (Aizawa et al., 2002).
Glucocorticoids are linked to neuronal cell death
(Sapolsky, 1996), in part through greater oxidative
stress damage, by increasing intra-neuronal levels
of glutamate and calcium and impairing antioxidant
defenses (McIntosh and Sapolsky, 1996). Glucocor-
ticoid administration increases plasma markers of
oxidative stress in mammals (Orzechowski et al.,
2002; Lin et al., 2004). It is unclear how these stress
hormones might affect telomerase and telomeres in
human PBMCs. The relationships between stress
hormones and telomerase activity in vitro are
currently under investigation (J.L. and E.H.B.,
unpublished results).
5.2. Telomerase and CVD risk
Low telomerase activity was consistently associ-
ated with proxy markers for the top six major risk
factors for CVD (Yusef et al., 2004): smoking,
abdominal adiposity, lipids, fasting glucose, blood
pressure, and psychosocial stress. Telomerase was
also associated with a Metabolic Syndrome cluster,
although this relationship was diminished after
controlling for BMI, and became of borderline
signiﬁcance.
Low telomerase, through an unidentiﬁed path-
way, could plausibly lead to increases in the
Metabolic Syndrome, the Metabolic Syndrome
factors could lead to decreased telomerase, or,
most likely, bidirectional pathways exist, as
described below. Finally, both may be indepen-
dently related to a third factor.
5.2.1. Lower telomerase contributing
to CVD processes
Low telomerase and its predicted eventual out-
come, shortened bulk telomeres, potentially
prevent the long-term tissue replenishment
necessary for endothelial and smooth muscle
cardiovascular cells, contributing to CVD risk.
Low telomerase in leukocytes may reﬂect low
telomerase in cardiovascular cells as well,
although this has not been explored. Prior
evidence, although limited to animal or in vitro
studies, suggests that low telomerase is associ-
ated with cardiovascular cell viability. In cardio-
myocytes, overexpression of the protein
component of telomerase (hTERT) inhibits apop-
tosis in culture (Oh, 2003). In vascular smooth
muscle cells, telomerase is related to cell
division, whereas telomerase inhibition is related
to reduced cell growth (Minamino and Kouremba-
nas, 2001). Telomerase regulates mitosis and
longevity of endothelial and progenitor endo-
thelial cells (Yang et al., 1999; Murasawa et al.,
2002). Telomerase could also play a signiﬁcant
role in early disease processes independently of
telomere length. Telomerase allows cells to grow
healthily, even those with short average telomere
length (Kim et al., 2003). Telomerase is protec-
tive of telomeric DNA even for long telomeres,
preventing them from occasional catastrophic
shortening that can cause cell growth arrest or
genomic instability (Chan and Blackburn, 2003).
Telomerase promotes stem cell proliferation even
in the absence of any telomerase enzymatic
functional capability (Sarin et al., in press).
5.2.2. Telomerase reﬂecting CVD processes
Telomerase could also be a marker, rather than
causal factor, of CVD risk. Low PBMC telomerase
activity could reﬂect overall organismal low telo-
merase activity, including low telomerase in
cardiovascular tissue. Thus, low telomerase may
simply be an early cellular indicator of disease
processes. Early factors, such as prenatal stress and
nutrition, can pre-program aspects of physiology
(obesity, insulin resistance, hypothalamic pituitary
adrenal responsiveness), causing later Metabolic
Syndrome (McMillen and Robinson, 2005). Such
early developmental factors might also affect
trajectories of cellular aging as well, by limiting
the total replenishment capabilities of cells. Such
limitation is seen in patients haploinsufﬁcient for
telomerase, who show premature bone marrow
stem cell exhaustion (Vulliamy et al., 2001;
Marrone et al., 2005).
5.2.3. CVD processes decreasing telomerase
The Metabolic Syndrome, through obesity or
insulin resistance, may accelerate cell aging
processes by causing, for example, greater
exposure to hyperglycemia (Blazer et al., 2002),
insulin (Gardner et al., 2005) and oxidative stress
associated with insulin resistance (Davi et al.,
2005). Given the relations we report here
between one-time measurement of leukocyte
telomerase activity level and stable factors such
as one’s body mass and cholesterol, it appears as
if snap–shot telomerase levels reﬂect relatively
stable levels over time. This may be especially
true in the current study given that no partici-
pants were ill, and that the collection conditions
were highly standardized, in terms of time of
day, fasting state, and stage of menstrual cycle.
Prolonged relative elevations of blood glucose
levels, even within the normal non-diabetic range
E.S. Epel et al. 284(range of 71–107 in this sample), might down-
regulate telomerase activity or expression, and
hence promote cell senescence, regardless of
telomere length (Chan and Blackburn, 2003; Kim
et al., 2003). Thus low telomerase may be part
of the cellular events that promote both early
disease as well as explain how later these risk
factors lead to frank CVD. Prospective cohort
studies are needed to indicate whether low
leukocyte telomerase activity should be included
among markers for CVD risk.
5.2.4. Telomere length and CVD risk: null ﬁndings
We found no relationship between mean bulk
telomere length (long vs. short telomere groups,
or by using correlations) and CVD risk. This might
be because of the relatively young healthy
sample analyzed in our study, or because
telomere length is associated with CVD through
non-traditional pathways (i.e. independent of
common CVD risk factors). In one study, short
telomere length conferred a three-fold risk of
premature myocardial infarction, but this
relationship was independent of established risk
factors (blood pressure, smoking, lipids, and
inﬂammation) (Brouilette et al., 2003). Lastly,
the failure to discern a relationship could be due
to methodological limitations for telomere length
measurement. The critical shortening of even one
telomere may trigger premature senescence of a
cell. Hence, average bulk telomere length in a
relatively young and healthy sample may not be
sensitive enough to detect early changes, such as
single strand DNA breaks in the telomere or rare
catastrophic shortening events that occur when
telomerase is deﬁcient (Chan and Blackburn,
2003), which would affect a cell’s longevity. In
addition, most risk factors in this sample, such as
blood pressure and fasting glucose, were in the
subclinical range, as might be expected given the
young age and health of the sample. Epidemio-
logical studies are needed to determine whether
our null ﬁndings are due to the lack of clinical
morbidity or relatively young age of the current
sample. Since telomere length was not correlated
with CVD risk factors over the whole sample,
telomerase may be a separate indicator from
telomere length, or more likely, an earlier
indicator than telomere length; of cell aging.
Eventually, with increasing age, if telomerase
activity indeed reﬂects stable levels, telomere
length may become shortened in the low
telomerase activity group. Supporting this
hypothesis, telomerase and telomere length
were marginally related (rZC.23, p!.06) in
the 30–50 year old participants (nZ47), but
they were not related among those under 30
years old (rZK.15, ns) (nZ9). If it is true that
telomerase is related to shorter telomeres mainly
with advancing age, then over time, we hypoth-
esize that insufﬁcient telomerase will lead to
shorter telomeres, reduced replenishment of
tissues, decreased efﬁciency of endothelial and
vascular functioning, and frank disease.
6. Summary
Our results show, for the ﬁrst time, that lower
levels of PBMC telomerase activity are associated
with increased excretion of stress hormones and
well-established physiological and behavioral risk
factors for CVD in a healthy sample. While in vitro
studies have suggested a crucial function of
telomerase in the health of cardiovascular-related
cells, this is the ﬁrst human study to show
links between telomerase and major CVD risk
factors. Interestingly, telomere length was not
associated with CVD risk factors in our relatively
young cohort. Telomere length is driven upward
by telomerase activity. Our ﬁnding that low
telomerase is associated with the major risk
factors for CVD, prior to any onset of clinically
manifested CVD or telomere shortening, suggest
that the telomere shortness previously reported in
CVD (Serrano and Andres, 2004) may be a direct
result of previously lower telomerase activity.
Thus, in younger individuals, such as the 20–50
year-old cohort we studied, telomerase activity
may be an earlier marker of preclinical disease
risk than telomere length, possibly acting as a
harbinger of subsequent telomere shortening that
manifests later in life.
These ﬁndings offer an important clue into
mechanisms—both of how telomere shortening is
linked to stress and CVD, and possibly of how
traditional risk factors promote CVD. It may be
highly clinically signiﬁcant that obesity and
smoking are linked to decreased telomerase.
These common risk factors could impair telomer-
ase enzyme function or interfere with its
expression. Perhaps most signiﬁcantly, our ﬁnd-
ings suggest early precursors of low telomerase
activity—neuroendocrine and autonomic stress
arousal. These ﬁndings also open up the possi-
bility that telomerase may be a useful marker for
monitoring health, such as a barometer for
examining effects of lifestyle and psychosocial
interventions on cardiovascular health. There is
yet much to be learned about human health from
Telomerase, stress arousal, and cardiovascular disease risk 285inquiring about state of mind, stress homeostasis,
and cellular events.
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